Intrua Financial, LLC Edwards Lifesciences Corp Transaction History

Intrua Financial, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$86.5 - $128.27 $28,026 - $41,559	-324 Reduced 12.31%	2,309 $220,000
Q1 2022 May 11, 2022	SELL	$101.96 - $128.34 $114,603 - $144,254	-1,124 Reduced 29.92%	2,633 $310,000
Q4 2021 Feb 14, 2022	SELL	$106.37 - $130.68 $34,038 - $41,817	-320 Reduced 7.85%	3,757 $487,000
Q3 2021 Oct 28, 2021	BUY	$102.91 - $122.75 $43,530 - $51,923	423 Added 11.58%	4,077 $473,000
Q2 2021 Aug 12, 2021	BUY	$83.84 - $104.76 $19,870 - $24,828	237 Added 6.94%	3,654 $406,000
Q1 2021 Apr 30, 2021	BUY	$78.68 - $90.67 $24,076 - $27,745	306 Added 9.84%	3,417 $329,000
Q4 2020 Feb 03, 2021	BUY	$71.69 - $91.23 $7,957 - $10,126	111 Added 3.7%	3,111 $284,000
Q3 2020 Nov 16, 2020	BUY	$67.19 - $87.44 $13,034 - $16,963	194 Added 6.91%	3,000 $245,000
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $161,457 - $215,921	2,806 New	2,806 $223,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Intrua Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Intrua Financial, LLC with notifications on news.